Page 55 - JCBP-2-3
P. 55

Journal of Clinical and
            Basic Psychosomatics                                   Proteomic analysis of mind-body psychotherapy in psoriasis




            Table 3. List of exosomal proteins showing significant differences between pre‑ and post‑MMIP
            S. No.  UniProt   Gene               Protein name                 Ratio    Q value Up/Down‑regulation
                  entry ID  name                                          (therapy/disease)
            1     Q5T750  XP32    Skin-specific protein 32                     0.11     0.034   Down
            2     P23528  CFL1    Cofilin-1                                    0.24     0.023   Down
            3     P19957  ELAF    Elafin                                       0.26     0.035   Down
            4     O00233  PSMD9   26S proteasome non-ATPase regulatory subunit 9  0.36  0.049   Down
            5     B4DRA0  B4DRA0  Highly similar to RNA-binding region-containing protein 2   0.36  0.039   Down
            6     P14618  PKM     Pyruvate kinase PKM                          0.43     0.037   Down
            7     P81605  DCD     Dermcidin                                    0.43     0.033   Down
            8     P50552  VASP    Vasodilator-stimulated phosphoprotein        0.48     0.034   Down
            9     P62736  ACTA2   Actin, aortic smooth muscle                  0.49     0.027   Down
            10    P30086  PEBP1   Phosphatidylethanolamine-binding protein 1   0.52     0.005   Down
            11    Q99972  MYOC    Myocilin                                     0.52     0.009   Down
            12    Q92876  KLK6    Kallikrein-6                                 0.66     0.042   Down
            13    P69905  HBA1    Hemoglobin subunit alpha                     2.07     0.038   Up
            14    Q0ZCH6  Q0ZCH6  Immunoglobulin heavy chain variable region (Fragment)  2.16  0.007   Up
            15    Q01518  CAP1    Adenylyl cyclase-associated protein 1        3.56     0.025   Up
            16    P60660  MYL6    Myosin light polypeptide 6                  10.44     0.017   Up
            Abbreviation: MMIP: Mongolian mind-body interactive psychotherapy.

            (Figure 2A and Table 2). A cluster analysis chart was plotted   www.kegg.jp/dbget-bin/www_bget?map03010) and apelin
            based on these DEPs. The results showed the significantly   signaling pathways (https://www.kegg.jp/dbget-bin/www_
            different proteins between the patients and HCs (disease vs.   bget?map04371) were significantly involved in psoriasis
            health; Q value < 0.05; Figure 2B). Among the 41 DEPs, nine   (p <0.05). Subsequently, the DEPs were imported into the
            of them were immunoglobulins (Igs)-derived molecules   STRING  database  (STRING  11.0)  to perform  network
            such as IGHG3, IGKV2-24, JCHAIN, Q8NCL6 (no gene   interaction analysis of protein-protein relationships in the
            ID, instead of UniProt entry ID, same for others), IGHM,   first 100 confidence intervals. As Figure 2D shows, actin
            Q0ZCH6, Q0ZCF6, and IG-like proteins (A2NYU9,      alpha 2 (ACTA2) upregulation was associated with various
            B1N7B9). Keratin 17 (KRT17) and plakophilin-1 (PKP1)   ribosomal protein (RS) proteins and collagen alpha-1
            were found to be decreased in patients with psoriasis   chain  (COLA1),  which  was  also  connected  to  cadherin
            compared to HCs (Figure 2B and Table 2). Further, four   EGF LAG seven-pass G-type receptor 2 (CELR2).
            types of ribosomal protein (RS), namely, 40S ribosomal
            protein S6 (RS6), 40S ribosomal protein S23 (RS23), 40S   3.4. DEPs in psoriasis identified from comparison
            ribosomal protein S3A (RS3A), and 40S ribosomal protein   between pre- and post-MMIP
            S15A (RS15A), which are proteins involved in the cellular   Comparative analysis of exosomal proteins before
            process of translation, were observed to be increased   and after the MMIP unveiled 16 DEPs, as shown in
            in psoriasis patients compared with HCs (Figure  2B   Figure 3A and  B. Among them, 12 of the proteins were
            and Table 2). In addition, inflammation-related proteins,   significantly decreased, and four were increased. The levels
            such  as phosphatidylethanolamine-binding protein  1   of  ELAF,  PSMD9,  VASP,  ACTA2,  PEBP1,  and  adenylyl
            (PEBP1), calpain small subunit 1 (CPNS1), complement   cyclase-associated protein 1 (CAP1) in psoriasis patients
            C3   (CO3),  vasodilator-stimulated  phosphoprotein  decreased significantly and Ig of Q0ZCH6 was increased
            (VASP), 26S proteasome non-ATPase regulatory subunit 9   after the MMIP. Nine proteins were only observed in
            (PSMD9), and elafin (ELAF), were upregulated. Among   the group receiving the therapy. These proteins were
            these proteins, ELAF achieved the highest level of   skin, metabolic, or other function-related proteins, such
            expression in psoriasis as compared to HCs (Table 2).  as skin-specific protein 32 (XP32), cofilin-1 (COF1),
              To gain further insight, we performed a KEGG pathway   dermcidin (DCD), myocilin (MYOC), KLK6, myosin
            and PPI analysis (Figure 2C and D). The KEGG pathway   light polypeptide 6 (MYL6), and pyruvate kinase (PKM)
            analysis showed that two pathways of the ribosome (https://  (Figure 3B and Table 3).


            Volume 2 Issue 3 (2024)                         7                               doi: 10.36922/jcbp.2381
   50   51   52   53   54   55   56   57   58   59   60